Warning letter
Glencoe Venterinary Clinic, P.A.: warning letter of Sep 13, 2001
FDA warning letter UCM178572 · Minneapolis District Office
Key facts
| Reference number | UCM178572 |
|---|---|
| Company | Glencoe Venterinary Clinic, P.A. |
| Subject | Extralabel Drug Use/Phenylbutazone/Unaproved New Animal Drug/Adulterated |
| Issue date | Sep 13, 2001 |
| Posted date | Sep 13, 2001 |
| Issuing office | Minneapolis District Office |
| Product type | Drugs |
| CFR sections cited | 530 |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: